Heiner Dreismann

Heiner Dreismann

Directeur/Membre du Conseil chez MYRIAD GENETICS, INC.

Fortune : 1 M $ au 30/06/2026

71 ans
Health Technology
Commercial Services
Health Services

Profil

Heinrich Dreismann is the founder of Homestead Clinical Corp.
Currently, the roles include Chairman at Apton Biosystems LLC, MOBILion Systems, Inc., and Biofidelity Ltd. since 2020; Independent Director at Myriad Genetics, Inc. since 2010; Director at Singulex, Inc. since 2007, BioCision LLC, HistoRx, Inc. since 2010, Roche Diagnostics Seattle, Inc. since 2007, GestVision, Inc., Spinomix SA since 2011, DNA Script SAS, Inflammatix, Inc. since 2023, MedCision LLC; Senior Independent Non-Executive Director at Congenica Ltd. since 2019; Director at Nucleix Ltd. since 2016; Member of the New York Academy of Sciences, American Society for Microbiology, European Diagnostic Manufacturers Association; and Advisor at Cambridge Innovation Capital Ltd. Former roles include Chief Executive Officer at FasTraq, Inc. and StageZero Life Sciences Ltd.; President & Chief Executive Officer at Roche Molecular Systems, Inc. from 2000 to 2006; Chief Executive Officer at Vectrant Technologies, Inc. from 2006 to 2009; Chairman at Sense Biodetection Ltd.; Director at Ngen, Inc. from 2006 to 2009, Interpace Biosciences, Inc. from 2014 to 2016, Many Bright Ideas Technologies, Inc. from 2012 to 2014, Shrink Nanotechnologies, Inc. from 2009 to 2011, Ignyta, Inc. from 2013 to 2018; and Director at ChondroGene Ltd., Iconix Biosciences, Inc., Stemina Biomarker Discovery, Inc., BioHelix Corp., Magellan Diagnostics, Inc., Celula, Inc., AdvanDx, Inc., Adarza BioSystems, Inc., Sirius Genomics, Inc., Oxford BioDynamics Plc, Fore Biotherapeutics, Inc., Many Bright Ideas Technologies, Inc., F.
Hoffmann-La Roche Ltd., and Roche Diagnostics France SASU from 1997 to 1999.
Education includes graduate and doctorate degrees from the University of Münster.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
04/06/2026 231 145 ( 0,24% ) 1 M $ 30/06/2026

Postes actifs de Heiner Dreismann

SociétésPosteDébut
MYRIAD GENETICS, INC. Directeur/Membre du Conseil 10/06/2010
Corporate Officer/Principal -
Corporate Officer/Principal -
Directeur/Membre du Conseil 01/02/2011
Directeur/Membre du Conseil -
Directeur/Membre du Conseil -
Directeur/Membre du Conseil -
European Diagnostic Manufacturers Association
Corporate Officer/Principal -
Directeur/Membre du Conseil 05/11/2019
░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░ ░░░ ░░░░░░░░░░ ░ ░░░░░░░ -
░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ -

Anciens postes connus de Heiner Dreismann

SociétésPosteFin
░░░░░░░ ░░░░░ ░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░ ░░░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Heiner Dreismann

Formation de Heiner Dreismann

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

72

Relations au 1er degré

46

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées46

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Services

Consumer Services

Health Technology

Commercial Services

Health Services

Health Technology

Commercial Services

Health Services

Health Technology

Electronic Technology

Health Technology

Vectrant Technologies, Inc.

Electronic Technology

Health Technology

Commercial Services

European Diagnostic Manufacturers Association

Health Technology

Health Technology

Technology Services

Health Services

Finance

Health Services

Health Technology

Technology Services

Health Technology

Technology Services

Health Services

Commercial Services

Health Technology

Technology Services

Health Technology

Commercial Services

Health Technology

  1. Bourse
  2. Insiders
  3. Heiner Dreismann